# REMIFENTANIL HYDROCHLORIDE

NDC: 0143-9391
Generic name: REMIFENTANIL HYDROCHLORIDE
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210515

FDA application: ANDA210594

## Active ingredients

- REMIFENTANIL HYDROCHLORIDE: 1 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9d289052-1eb6-4ba2-a3ca-d2e542a052ae